$49.99
This item has been third-party tested by accredited U.S. laboratories and confirmed to meet a minimum purity of 98% through rigorous verification standards.
Updated COA's
Secure Shipping Guaranteed
Verified for Purity
$49.99
Research Chemical products are third-party tested by MZ Biolabs, an independent laboratory based in Arizona. Each batch is analyzed to ensure accuracy, purity, and that all specifications are met.
Research Chemical proudly offers DSIP (Delta Sleep-Inducing Peptide), a high-quality synthetic peptide that has captured the attention of the scientific community. Recognized for its studies on sleep regulation and modulation of the stress response, DSIP stands as a notable peptide in sleep science, highlighting its impact on the central nervous system.
Comprising a chain of nine amino acids, DSIP has gained renown for its potential effects on sleep architecture, stress reduction, and neuroprotection. This unique combination of attributes positions DSIP as an intriguing molecule for in-depth investigation into sleep disorders, chronic insomnia, and related conditions. Its influence on sleep patterns and stress management offers an enticing avenue for potential therapeutic interventions, warranting comprehensive exploration within the domain of sleep and neurobiology in the scientific community.
The research on DSIP suggests various experimental potential in the laboratory setting, including:
Accumulating studies suggest that DSIP, the Delta Sleep-Inducing Peptide available at Research Chemicals, plays a pivotal role in shaping sleep architecture. Based on current research, this synthetic peptide showcases a notable potential to promote deep sleep and regulate rapid eye movement (REM) sleep. This is indicative of its potential therapeutic benefits for individuals grappling with sleep disorders, notably chronic insomniac patients, with further research and exploration.
The ability of DSIP to modulate sleep patterns by enhancing deep sleep and influencing REM sleep offers a promising avenue for further studies. Understanding its impact on sleep architecture presents an exciting opportunity to unravel the mechanisms through which DSIP can potentially contribute to improved sleep quality and, consequently, better management of sleep-related disorders.
Current research highlights the potential neuroprotective effects of DSIP, a Delta Sleep-Inducing Peptide available through Research Chemical. This synthetic peptide exhibits the capacity to enhance antioxidant defenses and mitigate oxidative stress, thereby providing protection against neuronal damage. These laboratory research findings hold promise for potential implications in addressing neurodegenerative diseases.
Recent laboratory investigations have shed light on the immunomodulatory properties of DSIP, a Delta Sleep-Inducing Peptide. This synthetic peptide demonstrates the potential to regulate cytokine production, modulate immune cell activity, and induce anti-inflammatory effects. These characteristics suggest a potential application for immune-related disorders that impact the immune system.
This synthetic peptide has been shown to mitigate the release of stress-related hormones, including cortisol, highlighting its potential to alleviate the physiological impact of stress in recent scientific literature. Moreover, DSIP demonstrated anxiolytic effects, offering promising possibilities for managing stress and addressing anxiety disorders.
DSIP is sold strictly as a research chemical. It is not approved for human consumption, medical treatment, or veterinary use.
For Research Use Only: DSIP is supplied exclusively for controlled laboratory testing and in vitro research.
Abuse Potential: Some individuals may attempt to misuse DSIP for anxiety, cognitive enhancement, or other non-research purposes. Such use is unsafe, unregulated, and may carry serious health risks.
Unestablished Safety: The pharmacology, toxicology, and long-term safety of DSIP in humans have not been established.
Liability Disclaimer: Research Chemical assumes no responsibility for misuse, abuse, or handling of DSIP outside of properly controlled research environments.
By purchasing DSIP, you confirm that it will be used solely for lawful scientific research.
1. Djonlagic, I., Saboisky, J., Carusona, A., Stickgold, R., & Malhotra, A. (2012). Increased sleep fragmentation leads to impaired off-line consolidation of motor memories in humans. PloS one, 7(3), e34106.
2. Amzica, F., & Steriade, M. (1997). The K-complex: its slow (< 1-Hz) rhythmicity and relation to delta waves. Neurology, 49(4), 952-959.
3. McCarley, R. W. (2007). Neurobiology of REM and NREM sleep. Sleep medicine, 8(4), 302-330.
4. Lichtigfeld, F. J., & Gillman, M. A. (1994). Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state. International journal of neuroscience, 76(1-2), 17-33.
5. Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Molecular Neurodegeneration. 2011 Dec;6:85. doi: 10.1186/1750-1326-6-85.
6. Shvetsov, A. V., Batotsyrenova, E. G., Dyuzhikova, N. A., Kashuro, V. A., Lapina, N. V., Dolgo-Saburov, V. B., & Ivanov, M. B. (2016). STUDY OF THE COMBINED INFLUENCE OF SODIUM THIOPENTAL AND DELTA SLEEP-INDUCING PEPTIDE ON ANTIOXIDANT DEFENSE SYSTEM IN RATS. Toxicological Review, (5), 49-52.
7. Segal, M. B., Zlokovic, B. V., Segal, M. B., & Zlokovic, B. V. (1990). Immunological and other aspects of the blood—brain barrier. The Blood-Brain Barrier, Amino Acids and Peptides, 179-188.
8. Vignati, S., Albertini, V., Rinaldi, A., Kwee, I., Riva, C., Oldrini, R., … & Catapano, C. V. (2006). Cellular, molecular consequences of peroxisome proliferator-activated receptor-δ activation in ovarian cancer cells. Neoplasia, 8(10), 851-IN12.
9. Graf, M. V., & Kastin, A. J. (1984). Delta-sleep-inducing peptide (DSIP): a review. Neuroscience & Biobehavioral Reviews, 8(1), 83-93.
10. Sailesh, K. S., & Mukkadan, J. (2013). Controlled vestibular stimulation: A novel treatment for insomnia. System, 12, 13.
11. Moore, P., Landolt, H. P., Seifritz, E., Clark, C., Bhatti, T., Kelsoe, J., … & Gillin, J. C. (2000). Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology, 23(6), 601-622.
12. Korbonits, M., Kaltsas, G., Perry, L. A., Putignano, P., Grossman, A. B., Besser, G. M., & Trainer, P. J. (1999). The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. The Journal of Clinical Endocrinology & Metabolism, 84(7), 2489-2495.
Please note that the above references provide evidence for the potential benefits of DSIP Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
The effects of DSIP (Delta Sleep-Inducing Peptide) indicated by recent laboratory research studies include promoting slow-wave sleep, improve sleep patterns, regulate blood pressure, stress-protective potency, and potentially influencing pain perception and chronic pain syndromes.
DSIP is a hypothalamic hormone that plays a primary role in sleep wake cycles, sleep regulation and the promotion of slow-wave sleep. Studies show promise in improving sleep patterns, reducing pain perception, and regulating blood pressure.
DSIP (Delta Sleep-Inducing Peptide) has not been reported to have significant side effects, and it is generally well-tolerated in laboratory settings. Clinical studies have shown that it has an effect on central nervous system functioning where it can promote sleep without causing major adverse effects. Human sleep behavior is still under study as these are research chemicals used in clinical settings.
DSIP has potential therapeutic benefits, including promoting slow-wave sleep, improving sleep patterns, and regulating blood pressure as explored by recent researchers. Additionally, research shows it exhibits stress-protective potency and may have implications in pain perception and chronic pain syndromes.
If you are searching for where to buy DSIP peptide online, you will come across many options. Several companies offer peptides, but unfortunately, not all prioritize quality assurance.
Research Chemical stands out in this landscape. We’re committed to delivering only the finest DSIP peptide for sale online. When you decide to buy peptides from us, rest assured, you’re opting for top-tier quality.
Our peptides undergo rigorous testing, verified by esteemed American third-party laboratories—labs that welcome phone or email inquiries to confirm their certificate’s authenticity. Our peptides are preserved in lyophilized form inside glass containers and maintained in cool conditions to uphold their potency.
You can trust in our assortment of top-grade research chemicals, all backed by a reassuring 60-day money-back guarantee. Plus, enjoy free shipping for orders over $149, with expedited shipping options available. Subscribers to our newsletter enjoy a 10% discount, and choosing cryptocurrency for payment affords an additional 10% off.
Choose Research Chemical, and you’re not just selecting a seller; you’re opting for verified excellence, secured packaging, prompt deliveries, and exemplary customer service. For any queries about our DSIP for sale or any other product, don’t hesitate to contact us. We’re here to assist promptly.
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
DSIP is sold strictly as a research chemical. It is not approved for human consumption, medical treatment, or veterinary use.
For Research Use Only: DSIP is supplied exclusively for controlled laboratory testing and in vitro research.
Abuse Potential: Some individuals may attempt to misuse DSIP for anxiety, cognitive enhancement, or other non-research purposes. Such use is unsafe, unregulated, and may carry serious health risks.
Unestablished Safety: The pharmacology, toxicology, and long-term safety of DSIP in humans have not been established.
Liability Disclaimer: Research Chemical assumes no responsibility for misuse, abuse, or handling of DSIP outside of properly controlled research environments.
By purchasing DSIP, you confirm that it will be used solely for lawful scientific research.
1. Djonlagic, I., Saboisky, J., Carusona, A., Stickgold, R., & Malhotra, A. (2012). Increased sleep fragmentation leads to impaired off-line consolidation of motor memories in humans. PloS one, 7(3), e34106.
2. Amzica, F., & Steriade, M. (1997). The K-complex: its slow (< 1-Hz) rhythmicity and relation to delta waves. Neurology, 49(4), 952-959.
3. McCarley, R. W. (2007). Neurobiology of REM and NREM sleep. Sleep medicine, 8(4), 302-330.
4. Lichtigfeld, F. J., & Gillman, M. A. (1994). Psychotropic analgesic nitrous oxide and neurotransmitter mechanisms involved in the alcohol withdrawal state. International journal of neuroscience, 76(1-2), 17-33.
5. Mu Y, Gage FH. Adult hippocampal neurogenesis and its role in Alzheimer’s disease. Molecular Neurodegeneration. 2011 Dec;6:85. doi: 10.1186/1750-1326-6-85.
6. Shvetsov, A. V., Batotsyrenova, E. G., Dyuzhikova, N. A., Kashuro, V. A., Lapina, N. V., Dolgo-Saburov, V. B., & Ivanov, M. B. (2016). STUDY OF THE COMBINED INFLUENCE OF SODIUM THIOPENTAL AND DELTA SLEEP-INDUCING PEPTIDE ON ANTIOXIDANT DEFENSE SYSTEM IN RATS. Toxicological Review, (5), 49-52.
7. Segal, M. B., Zlokovic, B. V., Segal, M. B., & Zlokovic, B. V. (1990). Immunological and other aspects of the blood—brain barrier. The Blood-Brain Barrier, Amino Acids and Peptides, 179-188.
8. Vignati, S., Albertini, V., Rinaldi, A., Kwee, I., Riva, C., Oldrini, R., … & Catapano, C. V. (2006). Cellular, molecular consequences of peroxisome proliferator-activated receptor-δ activation in ovarian cancer cells. Neoplasia, 8(10), 851-IN12.
9. Graf, M. V., & Kastin, A. J. (1984). Delta-sleep-inducing peptide (DSIP): a review. Neuroscience & Biobehavioral Reviews, 8(1), 83-93.
10. Sailesh, K. S., & Mukkadan, J. (2013). Controlled vestibular stimulation: A novel treatment for insomnia. System, 12, 13.
11. Moore, P., Landolt, H. P., Seifritz, E., Clark, C., Bhatti, T., Kelsoe, J., … & Gillin, J. C. (2000). Clinical and physiological consequences of rapid tryptophan depletion. Neuropsychopharmacology, 23(6), 601-622.
12. Korbonits, M., Kaltsas, G., Perry, L. A., Putignano, P., Grossman, A. B., Besser, G. M., & Trainer, P. J. (1999). The growth hormone secretagogue hexarelin stimulates the hypothalamo-pituitary-adrenal axis via arginine vasopressin. The Journal of Clinical Endocrinology & Metabolism, 84(7), 2489-2495.
Please note that the above references provide evidence for the potential benefits of DSIP Peptide as stated in the product description. For more in-depth information, kindly refer to these scholarly works.
Join our insider list for the latest research insights, product releases, and special offers—delivered straight to your inbox.
